Products

Below is a list of the treatments we currently offer via our Innovative Medicines Division. 
Please note: Not all treatments are available in all countries.

Aclasta

Product Information

  • Treatment of postmenopausal osteoporosis
  • Prevention of clinical fractures after a hip fracture
  • Treatment of osteoporosis in men
  • Treatment and prevention of glucocorticoid-induced osteoporosis
  • Prevention of postmenopausal osteoporosis
  • Treatment of Paget’s disease of bone

Active Ingredients - Zoledronic Acid 5mg

Product Division - Novartis Pharmaceuticals

Subcategory - Bisphosphonate